Biogen's injectable pen for Avonex receives FDA approval

02/28/2012 | Boston Globe (tiered subscription model), The

The FDA approved Biogen Idec's user-friendly injectable pen for delivering Avonex, a multiple sclerosis drug. Biogen also obtained approval for a dosing schedule intended to relieve flu-like symptoms normally associated with Avonex.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Food & Drug Associate
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations